= Additional active ingredients
Ofloxacin 200 mg.
PRESENTATION AND DOSSAGE
CPALETS: 20 x 200 mg
Bacterial infections due to ofloxacin-susceptible microorganisms, such as: acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pneumonia caused by pneumococci). Chronic and recurrent infections of the ear, nose and throat. (Ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci). Infections of soft tissues and skin. Infections of the bones and joints. Abdominal infections including infections in the pelvis, minor and bacterial enteritis. Infections of the kidney, urinary tract, and genital organs, gonorrhoea. Prevention of infections due to ofloxacin-susceptible pathogens in patients with a signifcant reduction in resistance to infections (.e.g in neutropenic state).
Pregnancy or lactation, hypersensitivity to ofloxacin, quinolones or to any of the excipients, epilepsy, convulsions, tendon problems, myasthenia gravis, G6PD deficiency, children and adolescents under 18 years of age.
Severe adverse reactions to other quinolones, the patient’s condition must be checked at regular intervals, strong sunlight and to avoid UV rays.
Stomach upsets, abdominal pain, loss of appetite, nausea, vomiting or diarrhea, headache, dizziness, sleep disorders, agitation and confusion, tachycardia, temporary decrease in blood pressure, itching and skin rashes, anaphylactic or anaphylactoid reactions in very rare instances, sweating.
Antacids, sucralfate, iron preparations, NSAIDs, oral anticoagulants, glibenclamide.
MANUFACTURER & DISTRIBUTER:
Manufacturer: Dexcel Ltd.